AHA Statement on Potential New Payment Model for Part B Drugs

 

 

Rick Pollack

AHA President and CEO

October 25, 2018

 

 

America’s hospitals and health systems are pleased that President Trump and his administration are focused on reining in out-of-control drug prices, which continue to threaten patient access and the ability of providers to deliver the highest quality of care. We look forward to reviewing the details of the model closely, including its impact on 340B hospitals and the patients they serve.

 

About the American Hospital Association

The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks and other providers of care. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit https://www.aha.org.

 

Contact: 

 

Marie Johnson, (202) 626-2351

Colin Milligan, (202) 638-5491

 

 

###

Related Resources

AHA Center for Health Innovation Market Scan
To understand what’s really driving Amazon's moves in pharmacy, it’s important to know the back story of Amazon’s $750 million-plus acquisition of PillPack, an…
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA letter to Senator Richard J.
Letter/Comment
Public
AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.